National Health Investors (NYSE:NHI - Get Free Report) will be releasing its earnings data after the market closes on Tuesday, November 5th. Analysts expect National Health Investors to post earnings of $1.12 per share for the quarter. National Health Investors has set its FY24 guidance at $4.52-4.56 EPS and its FY 2024 guidance at 4.520-4.560 EPS.Investors interested in participating in the company's conference call can do so using this link.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.10 by ($0.29). The business had revenue of $84.97 million during the quarter, compared to analyst estimates of $64.95 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business's revenue for the quarter was up 9.1% on a year-over-year basis. During the same period last year, the company earned $1.06 EPS. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
National Health Investors Price Performance
NYSE NHI traded up $1.80 during trading on Tuesday, reaching $77.47. 207,448 shares of the company traded hands, compared to its average volume of 188,405. National Health Investors has a 1-year low of $48.97 and a 1-year high of $86.13. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27. The stock's 50 day moving average price is $80.61 and its two-hundred day moving average price is $72.54. The company has a market cap of $3.37 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 4.72 and a beta of 1.04.
National Health Investors Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Friday, September 27th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.65%. The ex-dividend date of this dividend is Friday, September 27th. National Health Investors's dividend payout ratio (DPR) is 122.45%.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on NHI shares. Bank of America assumed coverage on National Health Investors in a report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price objective for the company. Wells Fargo & Company downgraded shares of National Health Investors from an "overweight" rating to an "equal weight" rating and lifted their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Truist Financial boosted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research report on Friday, August 30th. Finally, StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a report on Tuesday, October 15th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $73.29.
Get Our Latest Stock Report on National Health Investors
About National Health Investors
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.